{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:13:55Z","timestamp":1790097235280,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jhepr.2024.101123","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T06:48:35Z","timestamp":1716619715000},"page":"101123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Good long-term outcomes of primary sclerosing cholangitis in childhood"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4517-2458","authenticated-orcid":false,"given":"Anna","family":"Jerreg\u00e5rd Skarby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4546-826X","authenticated-orcid":false,"given":"Thomas","family":"Casswall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3858-6241","authenticated-orcid":false,"given":"Annika","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jhepr.2024.101123_bib1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2024.101123_bib2","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhepr.2024.101123_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhepr.2024.101123_bib4","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.26454","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history","volume":"58","author":"Deneau","year":"2013","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.jhepr.2024.101123_bib5","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ibd.22938","article-title":"Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease","volume":"18","author":"Boonstra","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.jhepr.2024.101123_bib6","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jhepr.2024.101123_bib7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/17474124.2018.1521719","article-title":"Primary sclerosing cholangitis in children versus adults: lessons for the clinic","volume":"12","author":"Adike","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101123_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpeds.2021.07.047","article-title":"Sclerosing cholangitis in pediatric inflammatory bowel disease: early diagnosis and management affect clinical outcome","volume":"238","author":"Hensel","year":"2021","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.jhepr.2024.101123_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1499-3872(16)60088-7","article-title":"Long-term follow-up of children and adolescents with primary sclerosing cholangitis and autoimmune sclerosing cholangitis","volume":"15","author":"Smolka","year":"2016","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"6","key":"10.1016\/j.jhepr.2024.101123_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/MPG.0000000000001368","article-title":"The natural history of primary sclerosing cholangitis in children: a large single-center longitudinal cohort study","volume":"63","author":"Valentino","year":"2016","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.jhepr.2024.101123_bib11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/2050640615616012","article-title":"Clinical course and prognosis of pediatric-onset primary sclerosing cholangitis","volume":"4","author":"Tenca","year":"2016","journal-title":"United Eur Gastroenterol J"},{"issue":"3","key":"10.1016\/j.jhepr.2024.101123_bib12","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hep.31393","article-title":"The sclerosing cholangitis outcomes in pediatrics (SCOPE) index: a prognostic tool for children","volume":"73","author":"Deneau","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhepr.2024.101123_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2024.101123_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cgh.2011.11.030","article-title":"Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children","volume":"10","author":"Mileti","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2024.101123_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC phenotypes of PSC-IBD","volume":"20","author":"Ricciuto","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"issue":"5","key":"10.1016\/j.jhepr.2024.101123_bib16","first-page":"e1237","article-title":"Incidence and characteristics of autoimmune hepatitis. Pediatrics","volume":"136","author":"Jim\u00e9nez-Rivera","year":"2015"},{"issue":"2","key":"10.1016\/j.jhepr.2024.101123_bib17","first-page":"567","article-title":"Primary sclerosing cholangitis and overlap features of autoimmune hepatitis","volume":"79","author":"Ricciuto","year":"2023","journal-title":"A\u00a0Coming Age Or Age-ist Problem? J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2024.101123_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhepr.2024.101123_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izad218","article-title":"Outcome of very early onset inflammatory bowel disease associated with primary sclerosing cholangitis: a multicenter study from the pediatric IBD porto Group of ESPGHAN","author":"Catassi","year":"2023","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.jhepr.2024.101123_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/CLD.0000000000000006","article-title":"Natural history and prognosis of pediatric PSC with updates on management","volume":"21","author":"Fuchs","year":"2023","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"12","key":"10.1016\/j.jhepr.2024.101123_bib21","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.dld.2021.04.028","article-title":"Treatment of primary sclerosing cholangitis","volume":"53","author":"Floreani","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.jhepr.2024.101123_bib22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/hep.31560","article-title":"Oral vancomycin, ursodeoxycholic acid, or No therapy for pediatric primary sclerosing cholangitis: a matched analysis","volume":"73","author":"Deneau","year":"2021","journal-title":"Hepatology"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924001277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924001277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T19:37:52Z","timestamp":1722973072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555924001277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2589555924001277"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101123","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Good long-term outcomes of primary sclerosing cholangitis in childhood","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101123"}}